Capital Fund Management (CFM)
SAGE

Capital Fund Management (CFM)’s Sage Therapeutics SAGE Stock Holding History

Capital Fund Management (CFM)’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-32,700
Closed -$613K – 2131
2024
Q1 		$613K Sell
32,700
-41,800
-56% -$964K ﹤0.01% 1827
2023
Q4 		$1.61M Buy
74,500
+41,700
+127% +$826K ﹤0.01% 1632
2023
Q3 		$675K Buy
+32,800
New +$947K ﹤0.01% 1738
2020
Q3 		– Sell
-13,700
Closed -$570K – 1368
2020
Q2 		$570K Buy
+13,700
New +$497K 0.01% 854
2018
Q3 		– Sell
-2,300
Closed -$360K – 2224
2018
Q2 		$360K Buy
+2,300
New +$361K ﹤0.01% 1725

Other funds holding SAGE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Capital Fund Management (CFM)'s SAGE Position: Q3 2024 in Review

Capital Fund Management (CFM) sold out of Sage Therapeutics (SAGE) in Q3 2024, closing a stake of 196,543 shares — an estimated $2.13M sold.

Capital Fund Management (CFM) first reported a position in SAGE in Q4 2017 and held it in 18 quarters. The position peaked at $4.74M in Q1 2021. 176 funds tracked by Wall St. Rank hold SAGE as of Q3 2024.

  • Capital Fund Management (CFM) reported no remaining Sage Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 196,543 Sage Therapeutics shares in Q3 2024, an estimated $2.13M.
  • Capital Fund Management (CFM) first reported a position in Sage Therapeutics in Q4 2017 and held it in 18 quarters.
  • Capital Fund Management (CFM)'s Sage Therapeutics position peaked at $4.74M in Q1 2021.
  • 176 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2024.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2024, filed 13 Nov 2024.